Moreover, consistent with our findings, a previous study revealed that plasma BNP was significantly elevated in patients with AD; additionally, it showed that BNP was one of the five markers that differentiated those with AD dementia and correlated with the CSF concentration of β-amyloid 1–42 and p-tau [34]. This evidence concerns the gene MAPT and Alzheimer disease.